Richard Pietras, M.D., Ph.D.

A Short Biography:

Dr. Richard Pietras earned his MD and PhD degrees at UCLA. Later, he completed a Residency in Internal Medicine and a Fellowship in Hematology-Oncology at the UCLA Medical Center. He is currently a Professor of Medicine in the Division of Hematology/Oncology at the Geffen School of Medicine at UCLA. To date, Dr. Pietras has contributed more than 100 research publications, and this work has received more than 12,000 citations in the medical literature. His research work has focused largely on the biology and treatment of women's cancers, with an aim toward translation of basic research findings to the clinic. His work on hormones and HER-2 growth factor receptors in human breast cancer contributed to the preclinical and clinical development of novel targeted therapies, such as Herceptin, for breast cancer. More recently, Dr. Pietras has devoted his efforts to developing new treatments for hormone-resistant breast cancer and to understanding the role of estrogen and growth factor receptors in lung cancer in women. His laboratory and clinical work has been supported by research grants from federal agencies as well private foundations. Dr. Pietras was honored to be selected as Director of the Stiles Program in Integrative Oncology at the Jonsson Comprehensive Cancer Center at UCLA. He has lectured at many national and international scientific meetings and has received many awards from professional and academic organizations for his research contributions.

Work Titles
UCLA Professor, Medicine Professor, Hematology-Oncology
Education:
Degrees:
M.D., UCLA School of Medicine, 1986
Ph.D.
Fellowship:
1989 - 1992 UCLA School of Medicine
Internship:
1986 - 1987 West Los Angeles Veterans Affairs Med Ctr
Residency:
1987 - 1989 West Los Angeles Veterans Affairs Med Ctr
Certifications:
Certifications:
1995 American Board of Internal Medicine
1990 American Board of Internal Medicine

Contact Information:

Work Email Address:

rpietras@ucla.edu


Work Phone Number:

(310) 825-9769

Office Address:

Medicine-Hem/Oncology
700 Tiverton Ave
11-934 Factor Bldg.
CAMPUS - 167817
Los Angeles, CA 90095


Publications:

Garon Edward B, Pietras Richard J, Finn Richard S, Kamranpour Naeimeh, Pitts Sharon, Márquez-Garbán Diana C, Desai Amrita J, Dering Judy, Hosmer Wylie, von Euw Erika M, Dubinett Steven M, Slamon Dennis J   Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013; 8(3): 270-8.
Kazmi Nadiyah, Márquez-Garbán Diana C, Aivazyan Lilia, Hamilton Nalo, Garon Edward B, Goodglick Lee, Pietras Richard J   The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer Lung cancer management, 2012; 1(4): 259-272.
Mah Vei, Marquez Diana, Alavi Mohammad, Maresh Erin L, Zhang Li, Yoon Nam, Horvath Steve, Bagryanova Lora, Fishbein Michael C, Chia David, Pietras Richard, Goodglick Lee   Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer Lung cancer (Amsterdam, Netherlands), 2011; 74(2): 318-25.
Marquez-Garban Diana C, Mah Vei, Alavi Mohammad, Maresh Erin L, Chen Hsiao-Wang, Bagryanova Lora, Horvath Steve, Chia David, Garon Edward, Goodglick Lee, Pietras Richard J   Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer Steroids, 2011; 76(9): 910-20.
Márquez-Garbán Diana C, Chen Hsiao-Wang, Goodglick Lee, Fishbein Michael C, Pietras Richard J   Targeting aromatase and estrogen signaling in human non-small cell lung cancer Annals of the New York Academy of Sciences, 2009; 1155(9): 194-205.
Levin Ellis R, Pietras Richard J   Estrogen receptors outside the nucleus in breast cancer Breast cancer research and treatment, 2008; 108(3): 351-61.
Mah Vei, Seligson David B, Li Ai, Márquez Diana C, Wistuba Ignacio I, Elshimali Yahya, Fishbein Michael C, Chia David, Pietras Richard J, Goodglick Lee   Aromatase expression predicts survival in women with early-stage non small cell lung cancer Cancer research, 2007; 67(21): 10484-90.
Pietras Richard J, Márquez-Garbán Diana C   Membrane-associated estrogen receptor signaling pathways in human cancers Clinical cancer research : an official journal of the American Association for Cancer Research, 2007; 13(16): 4672-6.
Márquez-Garbán Diana C, Chen Hsiao-Wang, Fishbein Michael C, Goodglick Lee, Pietras Richard J   Estrogen receptor signaling pathways in human non-small cell lung cancer Steroids, 2007; 72(2): 135-43.
Sartippour Maryam R, Pietras Richard, Marquez-Garban Diana C, Chen Hsiao-Wang, Heber David, Henning Susanne M, Sartippour Guilan, Zhang Liping, Lu Ming, Weinberg Olga, Rao Jian Yu, Brooks Mai N   The combination of green tea and tamoxifen is effective against breast cancer Carcinogenesis, 2006; 27(12): 2424-33.
Márquez Diana C, Chen Hsiao-Wang, Curran Edward M, Welshons Wade V, Pietras Richard J   Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer Molecular and cellular endocrinology, 2006; 246(1-2): 91-100.
Pio Betty S, Park Cecilia K, Pietras Richard, Hsueh Wei-Ann, Satyamurthy Nagichettiar, Pegram Mark D, Czernin Johannes, Phelps Michael E, Silverman Daniel H S   Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 2006; 8(1): 36-42.
Weinberg Olga K, Marquez-Garban Diana C, Fishbein Michael C, Goodglick Lee, Garban Hermes J, Dubinett Steven M, Pietras Richard J   Aromatase inhibitors in human lung cancer therapy Cancer research, 2005; 65(24): 11287-91.
Pietras Richard J, Levin Ellis R, Szego Clara M   Estrogen receptors and cell signaling Science (New York, N.Y.), 2005; 310(5745): 51-3; author reply 51-3.
Pietras Richard J, Márquez Diana C, Chen Hsiao-Wang, Tsai Eugene, Weinberg Olga, Fishbein Michael   Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells Steroids, 2005; 70(5-7): 372-81.
Weinberg Olga K, Marquez-Garban Diana C, Pietras Richard J   New approaches to reverse resistance to hormonal therapy in human breast cancer Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2005; 8(4): 219-33.
Pietras Richard J, Weinberg Olga K   Antiangiogenic Steroids in Human Cancer Therapy Evidence-based complementary and alternative medicine : eCAM, 2005; 2(1): 49-57.
Pegram Mark D, Pietras Richard, Bajamonde Alex, Klein Pamela, Fyfe Gwen   Targeted therapy: wave of the future Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005; 23(8): 1776-81.
Garbán Hermes J, Márquez-Garbán Diana C, Pietras Richard J, Ignarro Louis J   Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription Proceedings of the National Academy of Sciences of the United States of America, 2005; 102(7): 2632-6.
Pegram Mark D, Konecny Gottfried E, O'Callaghan Carminda, Beryt Malgorzata, Pietras Richard, Slamon Dennis J   Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer Journal of the National Cancer Institute, 2004; 96(10): 739-49.
Nemere I, Pietras RJ, Blackmore PF   Membrane receptors for steroid hormones: signal transduction and physiological significance Journal of cellular biochemistry. , 2003; 88(3): 438-45.

Does this profile need updating? Contact Us